Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection (Q46856608)

25 December 2017

title

Seroreversion in subjects receiving antiretroviral therapy during acute/early HIV infection (English)

1 reference

25 December 2017

author

Douglas F. Nixon

9

1 reference

25 December 2017

Frederick M. Hecht

11

1 reference

25 December 2017

Michael P. Busch

3

Michael P Busch

1 reference

25 December 2017

7

Christopher Bentsen

1 reference

25 December 2017

Brandee L Pappalardo

2

Brandee L Pappalardo

1 reference

25 December 2017

Jay A. Levy

10

Jay A Levy

1 reference

25 December 2017

Annika C Karlsson

4

Annika C Karlsson

1 reference

25 December 2017

Clarissa A Ramstead

8

Clarissa A Ramstead

1 reference

25 December 2017

author name string

C Bradley Hare

1

1 reference

25 December 2017

Bruce H Phelps

5

1 reference

25 December 2017

Steven S Alexander

6

1 reference

25 December 2017

language of work or name

English

0 references

publication date

23 January 2006

1 reference

25 December 2017

Clinical Infectious Diseases

published in

1 reference

25 December 2017

volume

42

1 reference

25 December 2017

issue

5

1 reference

25 December 2017

page(s)

700-708

1 reference

25 December 2017

Vigorous HIV-1-Specific CD4 T Cell Responses Associated with Control of Viremia

cites work

1 reference

Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection

21 January 2018

1 reference

Discontinuation of antiretroviral therapy commenced early during the course of human immunodeficiency virus type 1 infection, with or without adjunctive vaccination

21 January 2018

1 reference

Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection

21 January 2018

1 reference

Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8 and CD4 T lymphocytes

21 January 2018

1 reference

The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responses

21 January 2018

1 reference

Virological and immunological effects of combination antiretroviral therapy with zidovudine, lamivudine, and indinavir during primary human immunodeficiency virus type 1 infection

21 January 2018

1 reference

Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection.

21 January 2018

1 reference

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

21 January 2018

1 reference

Early establishment of a pool of latently infected, resting CD4( ) T cells during primary HIV-1 infection

21 January 2018

1 reference

Frequent detection of acute primary HIV infection in men in Malawi

21 January 2018

1 reference

Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda

21 January 2018

1 reference

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

21 January 2018

1 reference

Preventing sexual transmission of HIV--new ideas from sub-Saharan Africa

21 January 2018

1 reference

HIV-1-specific CD4 T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

21 January 2018

1 reference

Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence

21 January 2018

1 reference

Enhanced ELISPOT detection of antigen-specific T cell responses from cryopreserved specimens with addition of both IL-7 and IL-15--the Amplispot assay.

21 January 2018

1 reference

HIV-1 seroreversion in an HIV-1-seropositive patient treated during acute infection with highly active antiretroviral therapy and mycophenolate mofetil

21 January 2018

1 reference

Absence of true seroreversion of HIV-1 antibody in seroreactive individuals

21 January 2018

1 reference

Seroreversion in patients with end-stage HIV infection.

21 January 2018

1 reference

Lack of Detectable Antibody in a Patient Infected with Human Immunodeficiency Virus

21 January 2018

1 reference

Human immunodeficiency virus infection and AIDS in a person with negative serology

21 January 2018

1 reference

The effect of highly active antiretroviral therapy on binding and neutralizing antibody responses to human immunodeficiency virus type 1 infection

21 January 2018

1 reference

Probability of viremia with HBV, HCV, HIV, and HTLV among tissue donors in the United States

21 January 2018

1 reference

Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing

21 January 2018

1 reference

Evolving strategies for diagnosing human immunodeficiency virus infection

21 January 2018

1 reference

Immune control of HIV-1 after early treatment of acute infection

21 January 2018

1 reference

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

21 January 2018

1 reference

Changes in Frequency of HIV‐1–Specific Cytotoxic T Cell Precursors and Circulating Effectors after Combination Antiretroviral Therapy in Children

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/500215

1 reference

25 December 2017

1 reference

25 December 2017